u/phase_two_pete

Yes. Two services on the same batch is the strongest thing an individual member can produce, and it is not expensive.

Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.

Corrected a cross-class dose comparison in the title. The body is untouched.

Cosigning on saying who paid. It is the whole basis on which this log is worth anything.

Do you have the trace, or only the summary?

Retitled to name the programme. It is what makes these threads findable in a year.

Yes — the shortage database is the source. The news coverage of it is downstream and usually a week behind.

Yes — nothing containing this is approved anywhere, and the threads keep forgetting it.

Corrected a cross-class dose comparison in the title. The body is untouched.

A stability statement is only meaningful with its conditions attached: temperature, duration, light exposure, and whether it covers powder or solution. Ask which.

That is area percent, not mass percent. The trace cannot give you the second one.

Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.

Is that from the publication or the press release?

Stocked line or made to order — did they say?

Has anyone here tested that compound at all?

Net peptide content on the certificate was well below the purity figure and both were honest. Chemistry, not deception.

Corrected a cross-class dose comparison in the title. The body is untouched.

if you are going to test, test the thing you actually received

Careful with the trend claim. Four results over two years is a very sparse series to draw a line through.

Retitled to name the programme. It is what makes these threads findable in a year.

no food and water restrictions is the practical difference people care about

Seasonality, which the source-page lane tables show clearly once you look for it.

The same origin, destination and carrier can differ by several days between February and August, and the temperature exposure differs by much more than the transit time suggests. A lane that is uneventful in winter is the same lane that generates the summer threads.

Two practical consequences. First, compare like months when you compare lanes. Second, ask which lines a supplier holds in regional stock — a shorter leg in July is worth more than any amount of packaging.

Is that baseline drawn by the software or by hand?

Kept every report as a PDF with the batch in the filename. Two years in, it is the most useful folder I own.

two labs, two gradients, two honest answers

Corrected a cross-class dose comparison in the title. The body is untouched.

Asked the pharmacist to check the wholesaler and had a definite answer in about four minutes.

the TGA shortage database is public and it is the source, not the news

Left up. It is careful about what is peptide and what is not, which is more than most threads here manage.

a result with no batch number is about a vial nobody can identify

crp_curious is right that the band matters more than the peak. Consistency across lots is the finding.

Correcting myself above: the transit was 8 days, not the figure I posted. Same conclusion, wrong number.

Was there a logger in the box?

Can you post the trace with the axes labelled?

That service reports area percent by default. Worth stating, since the thread has been comparing it to a mass figure.

Area percent or net peptide content?

Have you checked the shortage database directly?

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

Standing reminder: unapproved compound, research material is not for human use, and no schedules for other members.

do not import US advice into an Australian thread

if nobody has tested it here, that is a fact about us, not the compound